Safety is a prestigious Open Access journal published by MDPI, based in Switzerland, dedicated to advancing research in the fields of public health, environmental safety, and occupational health. Since its inception in 2015, the journal has become a vital resource for researchers, practitioners, and policymakers, striving to foster innovative solutions to safety challenges in various sectors. With its rigorous peer-review process and a 2023 ranking in the Q2 category for Safety Research, as well as a notable presence in public health and environmental disciplines, Safety is well-respected in academic circles, holding a Scopus rank of 37/109 in Safety Research and 87/207 in Safety, Risk, Reliability, and Quality. The journal aims to disseminate high-quality research that not only reflects the latest advancements but also aids in developing practical strategies for risk management and safety improvement. Supported by an open-access model, Safety ensures that cutting-edge research is readily available to a global audience, fostering collaboration and knowledge sharing for a safer environment.

Risk Management and Healthcare Policy is an esteemed Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of health policy and public health. Established in 2008, the journal fosters a rich dialogue among researchers, professionals, and students, focusing on innovative strategies for managing risks within healthcare systems. With a current impact factor reflected in its robust Scopus rankings—placing it in the top quartile (Q2) in both Health Policy and Public Health, Environmental and Occupational Health—the journal is a pivotal resource that shares critical insights and evidence-based practices. The journal not only covers empirical studies and analytical research but also promotes discussions on emerging challenges and opportunities within the healthcare sector. As a result, Risk Management and Healthcare Policy serves as a vital platform for disseminating high-quality research, fostering collaboration, and informing policy decisions aimed at enhancing health outcomes globally.

Pharmaceutical Medicine is a leading journal published by SPRINGER INT PUBL AG, dedicated to the field of pharmacology and pharmaceutical sciences. With ISSN 1178-2595 and E-ISSN 1179-1993, this journal serves as an essential platform for researchers and professionals to share groundbreaking findings and advancements in medication efficacy, safety, and innovative therapeutic strategies. Recognized for its contribution to the field, Pharmaceutical Medicine holds an impressive Q2 ranking in both Pharmacology and Medical Pharmacology categories, further underscored by its competitive Scopus rankings—positioned at 100/272 (63rd percentile) in Medical Pharmacology and 156/313 (50th percentile) in Pharmacology, Toxicology, and Pharmaceutics. Although it primarily operates on a traditional subscription basis, its robust academic reputation continues to attract a diverse readership worldwide. Addressed in the United Kingdom with facilities in Switzerland, the journal publishes authoritative articles from its inception in 2000 through to 2024, making it a pivotal resource for those seeking to enhance their understanding and application of pharmacological principles in clinical practice and research.

Pediatric Quality & Safety is an esteemed Open Access journal aimed at enhancing the well-being and care of pediatric patients through rigorous research and innovative practices. Published by Lippincott Williams & Wilkins since 2016, this journal provides a platform for the dissemination of critical findings in the fields of pediatrics, perinatology, and child health, boasting a respectable impact factor that places it in the Q2 category for 2023, ranking #173 out of 330 in its field. With a commitment to improving healthcare outcomes, Pediatric Quality & Safety not only offers comprehensive coverage of current research trends but also promotes best practices among healthcare professionals. It welcomes contributions from researchers, clinicians, and students alike, making it an invaluable resource for anyone dedicated to advancing pediatric care. The journal is accessible for readers worldwide, reflecting a growing emphasis on open-access knowledge and collaboration.

American Journal of Medical Quality is a pivotal publication in the field of healthcare quality and medical policy, published by Lippincott Williams & Wilkins. Since its inception in 1992, the journal has become a critical resource for researchers, practitioners, and students dedicated to improving patient care and health systems through evidence-based practices. With a current impact factor that reflects its significance in the arena of medicine and health policy, the journal falls within the Q3 category in both Health Policy and Medicine (Miscellaneous) as of 2023, ranking 253rd out of 636 in general medicine according to Scopus metrics. This underscores its relevance and prominence among peers. The journal's scope encompasses a diverse range of topics related to quality improvement initiatives, healthcare delivery systems, and policy analysis, making it an essential read for anyone invested in advancing medical quality standards and practices. While it is not an open-access journal, the content is meticulously curated to enrich the academic discourse and inform best practices in medical quality. With an ongoing commitment to addressing contemporary challenges in healthcare, American Journal of Medical Quality serves as an influential platform for advancing the knowledge and implementation of quality initiatives in medical settings.

DRUG SAFETY is a premier academic journal published by ADIS INT LTD, dedicated to the critical field of pharmacology and toxicology. Since its inception in 1990, the journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals by providing high-quality, peer-reviewed articles that inform and advance the understanding of drug safety and efficacy. With an impressive impact factor and its current Q1 categorization in Pharmacology across various sub-disciplines, DRUG SAFETY is ranked among the top journals in its field, reflecting its commitment to excellence in scientific research. The journal features a diverse range of studies, reviews, and case reports addressing contemporary issues in drug safety, making it an invaluable tool for academia and industry alike. Although it is not an open-access journal, the content is accessible to subscribers and institutions, ensuring that essential findings in drug safety reach the widest audience possible. As the field evolves, DRUG SAFETY remains at the forefront, driving innovation and improving regulatory practices worldwide.

Therapeutic Advances in Drug Safety is a prestigious open-access journal published by SAGE Publications Ltd that has made significant strides in the field of pharmacology since its inception in 2010. With an impressive impact factor that places it in the Q1 category for Pharmacology (medical), this journal ranks 61st out of 272 in Scopus, showcasing its global influence and commitment to advancing drug safety research. Based in the United Kingdom, it aims to bridge the critical gap between pharmacological innovation and clinical application, offering a platform for the dissemination of groundbreaking research, case studies, and expert reviews. Since adopting an Open Access model in 2019, the journal has significantly increased its reach, ensuring that vital findings in drug safety are accessible to researchers, healthcare professionals, and educators worldwide. As the field of drug safety continues to evolve, Therapeutic Advances in Drug Safety remains an essential resource for those dedicated to enhancing safe therapeutic practices and patient outcomes.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

The Turkish Journal of Anaesthesiology and Reanimation is an esteemed academic publication dedicated to advancing the fields of anesthesiology and pain medicine, as well as emergency medicine. Published by GALENOS PUBL HOUSE, this open access journal has been serving the global academic community since 2019, allowing for unrestricted dissemination of research findings and clinical practices. With its current categorization in the Q3 quartile for both anesthesiology and emergency medicine, the journal provides a valuable platform for researchers, professionals, and students alike, featuring rigorous peer-reviewed articles that enhance knowledge and inspire innovation. Located in Istanbul, Turkey, the journal actively contributes to an important dialogue in healthcare, making it a significant resource for those involved in improving patient care and outcomes. Researchers can also benefit from its increasing visibility, reflected in its Scopus rankings, positioning it within the competitive landscape of medical literature. Engage with cutting-edge research and ensure your contributions stand out in this vital field.

The British Journal of Anaesthesia is a leading peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing the field of anesthesiology and pain medicine. Since its inception in 1923, this prestigious journal has served as a vital resource for clinicians, researchers, and students, providing high-quality research articles, reviews, and clinical guidelines. With an impressive impact factor and a Scopus rank of #2 out of 136 in its category, it stands out as a Q1 journal, reflecting its significance and influence in the medical community. The journal aims to disseminate innovative research findings, enhance clinical practice, and contribute to the education of healthcare professionals globally. Although it does not offer open access, its rich archive and ongoing publication in the dynamic field of anesthesiology make it an essential reference for those seeking to stay at the forefront of this critical discipline. For more information, visit the journal’s dedicated webpage.